Dr. Wilber Sabiiti spent several days with the Porton Down PHE tuberculosis (TB) research team training them and optimising their Real-time PCR platform QuantiStudio TM Vii 6 and 7 Flex to perform Molecular bacterial load assay (MBLA).
Dr. Wilber Sabiiti recently presented some of his work at the UARC-TLD.
Hosted as part of the 6th East African Health and Scientific Research Conference and International trade fair the symposium was co-chaired by Dr. Wilber Sabiiti and Dr. Helen Meme of Kenya Medical Research Institute (KEMRI).
Dr Wilber Sabiiti has recently given a series of talks and training in different African countries showcasing the advantages of the molecular bacterial load assay (MBLA) and TWENDE work on developing model for rapid uptake of health research innovations into policy and practice.
TWENDE is building a model to increase effectiveness of implementing health research innovations. Dr. Wilber Sabiiti, the co-ordinator of TWENDE Consortium has recently completed the TWENDE site monitoring visits in Kenya, Tanzania and Uganda and witnessed the great progress made.
Professor Stephen Gillespie, Sir James Black Chair of Medicine, has been interviewed about tuberculosis for the Lancet Respiratory Medicine World TB day issue that is now available.
Dr Wilber Sabiiti and Dr Derek Sloan recently represented the University of St Andrews at the 8th EDCTP forum.
Researchers at the School of Medicine are one step closer to finding a shorter, more effective treatment for TB, according to a new paper published by The Lancet Infectious Diseases.
Professor Stephen Gillespie will give a presentation to the European Medicines Agency on 25 November.
The study was conducted as a partnership between the University of St. Andrews and Mozambique’s Natonal Institute of Health in Maputo.
- Page 1 of 2